RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 116.88
+6.88 (6.25%)
Sep 30, 2025, 3:00 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 64.46 billion as of October 3, 2025. Its market cap has increased by 474.20% in one year.
Market Cap
64.46B
Enterprise Value
65.86B
Revenue
2.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
116.88
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 64.46B, an increase of 125.98%. That is a compound annual growth rate of 18.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 64.46B | 389.84% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
| Nov 9, 2020 | 28.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |